loading...
Distributed by Mapi Research Trust
Distributed by Mapi Research Trust
Adapted from the original QUALIVEEN in 2004
A short version, SF-QUALIVEEN, was developed in 2008
Bonniaud V
Bonniaud V, Parratte B, Amarenco G, Jackowski D, Didier JP, Guyatt G. Measuring quality of life in multiple sclerosis patients with urinary disorders using the Qualiveen questionnaire. Arch Phys Med Rehabil. 2004 Aug;85(8):1317-23 (PubMed Abstract)
Bonniaud V, Jackowski D, Parratte B, Paulseth R, Grad S, Margetts P, Guyatt G. Quality of life in multiple sclerosis patients with urinary disorders: discriminative validation of the English version of Qualiveen. Qual Life Res. 2005 Mar;14(2):425-31 (PubMed Abstract)
Bonniaud V, Bryant D, Parratte B, Gallien P, Guyatt G. Qualiveen: a urinary disorder-specific instrument for use in clinical trials in multiple sclerosis. Arch Phys Med Rehabil. 2006 Dec;87(12):1661-3 (PubMed Abstract)
Bonniaud V, Bryant D, Parratte B, Guyatt G. Qualiveen, a urinary-disorder specific instrument: 0.5 corresponds to the minimal important difference. J Clin Epidemiol 2008;61(5):505-10 (PubMed Abstract)
Users must receive formal written permission to use the questionnaire before filling out a License Agreement with Mapi Research Trust.
Please contact:
Dr Souad MEILLASSOUX
Coloplast France
Phone: (+) 33 1 56 63 17 81
E-mail : frsme@coloplast.com
All requests have to be submitted through our online request management:
Fees may apply to your project.
Bonniaud V
Unité Pluridsciplinnaire de Pelvi-Périnéologie & Rééducation
CHU Dijon - Hôpital d'Enfants
14 rue Gaffarel - BP 77 908
21 079 Dijon CEDEX
France
Bonniaud V publications (PubMed)
Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66
Users must receive formal written permission to use the questionnaire before filling out a License Agreement with Mapi Research Trust.
Please contact:
Dr Souad MEILLASSOUX
Coloplast France
Phone: (+) 33 1 56 63 17 81
E-mail : frsme@coloplast.com
All requests have to be submitted through our online request management:
Fees may apply to your project.
Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.
The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.
Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.
The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.
For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).
If you wish to translate the questionnaire:
English for the UK and Canada:
Bonniaud V, Jackowski D, Parratte B, Paulseth R, Grad S, Margetts P, Guyatt G. Quality of life in multiple sclerosis patients with urinary disorders: discriminative validation of the English version of Qualiveen. Qual Life Res. 2005 Mar;14(2):425-31
Bonniaud V, Parratte B. [Cross-cultural adaptation of health-related quality of life questionnaire: English version of Qualiveen abstract] Ann Readapt Med Phys. 2006 Apr;49(3):92-9. Epub 2006 Feb 2. French
Bonniaud V, Bryant D, Parratte B, Gallien P, Guyatt G. Qualiveen: a urinary disorder-specific instrument for use in clinical trials in multiple sclerosis. Arch Phys Med Rehabil. 2006 Dec;87(12):1661-3
Bonniaud V, Bryant D, Parratte B, Guyatt G. Qualiveen, a urinary-disorder specific instrument: 0.5 corresponds to the minimal important difference. J Clin Epidemiol 2008;61(5):505-10.
Italian for Italy:
Bonniaud V, Bryant D, Pilati C, Menarini M, Lamartina M, Guyatt G, Del Popolo G. Italian version of Qualiveen-30: cultural adaptation of a neurogenic urinary disorder-specific instrument. Neurourol Urodyn. 2011 Mar;30(3):354-9 (PubMed abstract)
Persian for Iran:
Nikfallah A, Rezaali S, Mohammadi N, Abrishamkar M, Rezaei E, Sahraian MA, Pakpour AH, Yekaninejad MS. Translation, Cultural Adaptation and Validation of the Qualiveen-30 Questionnaire in Persian for Patients with Spinal Cord Injury and Multiple Sclerosis. Low Urin Tract Symptoms. 2015 Jan;7(1):42-9 (PubMed abstract)
Access to advanced descriptions of Clinical Outcome Assessments (COAs)